Navigation Links
New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension

n governmental oversight of pharmaceutical product development; the future scope of our patent coverage or that of third parties; the effects of any future litigation; general economic and business conditions, both internationally and within our industry, including exchange rate variations; and our future financing plans.

-- Ends --

For further information please contact

Nick Miles Director Communications & Investor Relations Speedel Hirschgässlein 11 CH - 4051 Basel Switzerland

T +41 (0) 61 206 40 00 D +41 (0) 61 206 40 14 F +41 (0) 61 206 40 01 M +41 (0) 79 446 25 21 E nick.miles@speedel.com www.speedel.com

Frank LaSaracina Managing Director Speedel Pharmaceuticals Inc 1661 Route 22 West P.O. Box 6532 Bridgewater, NJ 08807 United States of America

T +1 732 537 2290 F +1 732 537 2292 M +1 908 338 0501 E frank.lasaracina@speedel.com www.speedel.com

[1] Tekturna/ Rasilez ® are Novartis trademarks [2] HCTZ Hydrochlorothiazide [3] Tekturna HCT® is currently pending regulatory, including FDA, approval [4] Data on file.(Tekturna-HCT (aliskeren/hydrochlorothiazide) Combination Tablets Package Insert. March 13, 2007) [5] Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, and Angiotension-converting Enzyme Inhibitor, or an Angiotensin Recpetor Blocker Eoin O'Brien, John Barton, Juerg Nussberger, David Mulcahy, Chris Jensen, Patrick Dicker, Alice Stanton. Hypertension. 2007, 49,276-284 [6] Angiotensin Converting Enzyme Inhibitor [7] Calcium Channel Blocker [8] Diovan® is a Novartis Trademark [9] Angiotensin Receptor Blocker [10] Joint National Committee on prevention, detection, evaluation, and treatment of high b
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
2. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
3. Expert Opinion Highlights Avigens AV411 as Potential New Therapeutic for Neuropathic Pain and Opioid Withdrawal
4. Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
5. Ambrilia Highlights Encouraging Data for its HIV Integrase Inhibitor Program and Recent Developments at Annual Meeting
6. July Issue of Journal of Antimicrobial Chemotherapy Highlights Study of Factive Tablets for Five-Day Treatment of Community-Acquired Pneumonia
7. Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with Electroporation DNA Delivery Technology and New Devices at Gene Therapy Meeting
8. Presentations at 2007 European Stroke Congress Highlights New Direction for Viprinex (ancrod)
9. Data to be Presented at ASCO 2007 Highlights sanofi-aventis Commitment to Cancer Care and Research
10. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
11. New Critical Path Report Highlights Research Needed to Foster Generic Drug Development
Post Your Comments:
(Date:5/15/2008)...Trial Results Confirm Efficacy for Population Most...E, Calif., May 16 /-,Bayer ...uticals, Inc.,(Nasdaq: ONXX ) today announced tha...roved overall survival by 47.3 percent (HR=0.68;,p...on with advanced,hepatocellular carcinoma (HCC), o...
(Date:5/15/2008)... BASEL, Switzerland, May 15 /- Patien...rld,s most common cancers, can expect,further trea...erceptin(R),(trastuzumab) following new data that ... Clinical Oncology (ASCO) annual meeting in Chicag... will attend the meeting which,is the premier even...
(Date:5/15/2008)...- First in human clinical data highlight safety pr...advanced solid tumors -, BRISBANE, Calif., May 15... held biopharmaceutical company developing novel c...ing its lead PARP inhibitor, BSI-201, will,be pres...ology annual,meeting in Chicago., Findings will b...
(Date:5/15/2008)...hase II Data Presented at ASCO Showed Acceptable T...e of Grade 3 and 4 Neuropathy, WOODCLIFF LAKE, N....motherapeutic agent eribulin mesylate (E7389) demo...on of women with locally advanced or metastatic,br...r Phase II clinical,trial. The study also suggests...
Breaking Medicine Technology:Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 2Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 3Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 4Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 6New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 2New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 3New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 4New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 5New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 6BiPar Sciences Announces Clinical Data Presentations on Lead PARP Inhibitor, BSI-201, at 40th American Society of Clinical Oncology Annual Meeting 2Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 2Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 3Genes and environment interact in first graders to predict physical but not social aggression 2145 1Genes and environment interact in first graders to predict physical but not social aggression 2145 2The Ensign Group Inc Announces the Appointment of Covey C Christensen as President of Its Flagstone Subsidiary 11233 1The Ensign Group Inc Announces the Appointment of Covey C Christensen as President of Its Flagstone Subsidiary 11233 2New funding to charge energy research at UCL and the London Centre for Nanotechnology 3094 1New funding to charge energy research at UCL and the London Centre for Nanotechnology 3094 2Celebrity Cook Paula Deen and Husband Michael Groover Bring Smithfield Foods Helping Hungry Homes 28TM 29 Tour to L A 11232 1Celebrity Cook Paula Deen and Husband Michael Groover Bring Smithfield Foods Helping Hungry Homes 28TM 29 Tour to L A 11232 2Celebrity Cook Paula Deen and Husband Michael Groover Bring Smithfield Foods Helping Hungry Homes 28TM 29 Tour to L A 11232 3
...EM, & LUND, Sweden--(BUSINESS WIRE)--May 1, 20...e Biotech AB today,announced that data from a 36-w...Phase IIb study demonstrated that an oral 0.6 mg,d...d magnetic,resonance imaging (MRI) disease activit...rated. In addition, there was a favorable,trend to...
... confirmed EDSS progression reduced by 40 percent ...7 /PRNewswire/ -- Bayer HealthCare,Pharmaceuticals...te,initiation(1) of Betaseron(R) (interferon beta-...stive of multiple sclerosis (MS),can significantly...ent as measured by the Expanded Disability Status ...
Other Medicine Technology:Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 2Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 3Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 4Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 5Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 6First of Its Kind Data Show: Immediate Treatment of Early MS,Patients with Betaseron Significantly Delayed Permanent Disability 2First of Its Kind Data Show: Immediate Treatment of Early MS,Patients with Betaseron Significantly Delayed Permanent Disability 3First of Its Kind Data Show: Immediate Treatment of Early MS,Patients with Betaseron Significantly Delayed Permanent Disability 4
(Date:5/16/2008)...mpaign to Emphasize the Importance of Oral and Ove... -- National dental insurer United,Concordia Denta...tion,between Oral Health America and the British D...of oral health to overall health. Beginning May 18...tes for the first time,making it the largest inde...
(Date:5/16/2008)...m an international, multicenter Phase III clinical...erapy everolimus (RAD001) significantly delays can... cancer whose disease had worsened on other treatm...attending physician at Memorial Sloan-Kettering Ca... on May 31 at the annual meeting of the American S...
(Date:5/16/2008)...ds located just beneath the lining of the uterus (...rial cavity after uterine artery embolization (UAE...rding to a new study. , The study included 49 p...mination before and after UAE. The study found tha...ted to the endometrial cavity after UAE, said Sach...
(Date:5/16/2008)... Fundraiser Seeks to Raise $38 Million for Life-th...ire-USNewswire/ -- Walkers in nearly,every state w...- May 17 and,18 -- by participating in GREAT STRID...c Fibrosis Foundation announced today., May is Na...rosis is a,life-threatening genetic disease that c...
Breaking Medicine News(10 mins):Health News:United Concordia Dental Celebrates National Smile Month 2Health News:Drug fends off kidney cancer progression 2Health News:GREAT STRIDES Walks for Cystic Fibrosis Slated for 47 States This Weekend 2
... the AMA Rural Reference Group (AMARRG), Dr David ...y Transport Minister, Warren Truss, //of enhanceme...) was a welcome piece of rare good news for rural ...igned to attract GPs to work in country areas and ...
...xperts at University of Iowa are taking efforts to...cribed only when really needed.// Salmeterol is a...on with a corticosteroid, which is inhaled. The us...iorate the asthma for a few people with that condi...
...ers have uncovered important information about how... a critical step in DNA mutation that has eluded r...rs in the August edition of the Journal of the Ame... Institute of Technology have reported uncovering ...
...e about three severe, potentially fatal genetic di...that they can rupture in pregnancy and labor or ev...a blockers, curbing exercise, proactive blood vess...be helpful, but their usefulness varies according ...
Other Medicine News:Health News:RMIF Boost a Boon for Rural Health 2Health News:Salmeterol - to be used in combination & only when required 2Health News:Salmeterol - to be used in combination & only when required 3Health News:Elusive Step In DNA Mutation Uncovered By Researchers 2Health News:Elusive Step In DNA Mutation Uncovered By Researchers 3Health News:Elusive Step In DNA Mutation Uncovered By Researchers 4Health News:Scientists Review Loeys-Dietz Syndrome in the Largest Ever Study to date 2Health News:Scientists Review Loeys-Dietz Syndrome in the Largest Ever Study to date 3
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
Medicine Products: